Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
about
T helper 17 cell heterogeneity and pathogenicity in autoimmune diseaseInterleukin-23 drives innate and T cell-mediated intestinal inflammationAPC-derived cytokines and T cell polarization in autoimmune inflammationInterleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisTargeting Th17 Cells with Small Molecules and Small Interference RNAInterleukin-23: as a drug target for autoimmune inflammatory diseasesThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testingMultiple Sclerosis and T Lymphocytes: An Entangled StoryTriterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitisUnexpected phenotype of mice lacking Shcbp1, a protein induced during T cell proliferation.Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisThe chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injuryBeta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunityUstekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvementNeuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.IRAK-2 regulates IL-1-mediated pathogenic Th17 cell development in helminthic infection.Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17.RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease.Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study.T-bet, a Th1 transcription factor regulates the expression of Tim-3.T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.Th17 cells: effector T cells with inflammatory properties.Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune diseaseThe role of CXCL10 in the pathogenesis of experimental septic shockMajor role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells.The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humansGalectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice.Th17 cells in autoimmune demyelinating disease.Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.Animal models of atopic dermatitis.Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosusThe transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.Experimental autoimmune encephalomyelitis in the mouse.
P2860
Q24609737-A20E4C21-4E15-49B3-809A-4C9A013737FCQ24677051-A157414D-507F-4E53-8EFD-1DDF6439BB47Q24679426-3816D0AA-6A77-46DC-BF71-E9274A9A5544Q24681662-1F77EA88-47AB-4AEC-9BEF-89AAF56006A7Q26770523-0A69B8DB-C520-4318-9413-AE4523BD4951Q27009502-F6879EE6-52FC-437A-9F4D-6E566BA10F6CQ27687800-FEE98A46-E5CD-4C1C-B914-D5582C1F872DQ28086853-6EB1CDF2-C42D-4D70-AEDC-42BC5BF49FD6Q28394921-B3F1E70F-F4C8-471C-9677-A80F95012B86Q28513010-41F74AE2-EB31-4948-B1F3-4FA4AF32BB10Q28533202-2D890903-3DE6-4419-A6B9-12D492F3CDBBQ30439547-E3DE3F7D-CEFE-4358-89EA-3ED61C52358BQ30486061-D1A56ED6-5DB3-435B-8D34-DA920D82FAD5Q30620977-41F7FBEA-8A0D-4A6E-B82F-422178DDC677Q30699740-F0C1364C-24D1-4BE2-A3DE-60ECC678CDEAQ31036486-905F0FCD-C606-47A2-9ABF-78791BA4734DQ33326648-A3E50F2C-8256-45B1-A82C-F8C1310A46DFQ33611073-993238AF-E1D8-4881-9E26-31E50E2DB82CQ33625887-980BB9D9-7580-4657-9A50-B2802FC59026Q33636927-77E00AB3-9329-47E9-A17A-CD24D5952A30Q33681689-0E4C6FC7-535E-4244-B729-F05FC1ECF5D2Q33721890-22CCD84C-0D50-4C73-8EC5-269B0AC44662Q33723154-F0A38267-947E-47BA-B594-F9F93C45FC98Q33732092-04EC1756-0928-4C40-BBA2-94D78FFD2DE4Q33753720-524D9047-D80D-4CF3-89FF-B57A13DD7924Q33785953-1E5EFD99-D71A-4AF7-9160-1671077E770BQ33821851-71F7FC3B-2A91-46F7-A2B1-C07775E89108Q33829024-E4635AAA-94B0-4DC6-B9C6-D94980F5C8D5Q33833964-801BD3EB-F439-43AB-8C79-78CB9AE4C84CQ33834605-A2DA5135-E2FD-4B6A-9819-C76CD1760457Q33835084-0D3DC34F-5F47-44F4-AE38-FA9A29D56924Q33867796-7A3372E7-C4F4-4A06-8EB8-887FE1CD839FQ33894387-86EEA1BD-3088-4DA9-8ABD-AECF759AD563Q33911969-DB4B208A-D5CD-4E2E-BC11-BCC345242E9AQ33915252-45BF60E5-0A80-4548-BDC6-1533A74FBD87Q33923351-C9EA5C4F-4F36-40A8-A190-EDE38B9DA71AQ33927253-71062F4C-070B-4DBF-82B4-7B6B7F0D87E1Q33944262-6ED772EA-973C-45E3-AB7B-782048FDB9C0Q33987288-D1D8912B-3B15-4954-9942-050190646292Q34041971-C78E775D-361E-4221-8DFC-510CAFE66347
P2860
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@ast
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@en
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@nl
type
label
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@ast
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@en
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@nl
prefLabel
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@ast
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@en
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@nl
P2093
P2860
P356
P1476
Anti-IL-23 therapy inhibits mu ...... s autoimmune encephalomyelitis
@en
P2093
Barbara Joyce-Shaikh
Brent McKenzie
Christopher A Hunter
Claire L Langrish
Daniel J Cua
Jason S Stumhofer
Justin Low
Leonard Presta
Robert A Kastelein
Tatyana Churakovsa
P2860
P304
P356
10.1172/JCI25308
P407
P577
2006-05-01T00:00:00Z